Curosurf (Chiesi USA, Inc.)
Welcome to the PulseAid listing for the Curosurf drug offered from Chiesi USA, Inc.. This Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Chiesi USA, Inc. |
| NON-PROPRIETARY NAME: | poractant alfa |
| SUBSTANCE NAME: | PORACTANT ALFA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA] |
| ROUTE: | ENDOTRACHEAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1999-11-18 |
| END MARKETING DATE: | 0000-00-00 |
Curosurf HUMAN PRESCRIPTION DRUG Details:
| Item Description | Curosurf from Chiesi USA, Inc. |
| LABELER NAME: | Chiesi USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 80(mg/mL) |
| START MARKETING DATE: | 1999-11-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10122-510_7877d4dd-0042-4fb6-b467-dfd4f0d4e31e |
| PRODUCT NDC: | 10122-510 |
| APPLICATION NUMBER: | NDA020744 |
Other PORACTANT ALFA Pharmaceutical Manufacturers / Labelers:
